Named for the transversely isotropic shape's natural design and engineering properties, Hexagon Bio’s proprietary discovery platform enables drug development against novel targets, even targets previously considered undruggable. Hexagon’s proprietary algorithms can identify human targets of cryptic natural products, prioritizing among thousands of candidates, and create new chemical entities based on novel chemical scaffolds. This method of identifying novel secondary metabolites and their cognate proteins (therapeutic targets) from genomic data allows Hexagon to bypass traditional screening methods . . .
